My 3 Favorite Stocks to Buy Right Now (Nov 30, 2025)

Investors looking for value may like these three picks — all trading at less than 16 times forward earnings. Medtronic (MDT): A diversified medical‑device company whose valuation remains modest compared with high‑flying peers. With a long history of reliable dividend payouts, Medtronic offers a 2.7% yield — a nice feature for investors seeking income alongside potential growth. Pfizer (PFE): Currently out of the spotlight, Pfizer trades at a low price-to-earnings ratio, which could offer a margin of safety for long‑term investors. While the drugmaker faces headwinds — including upcoming patent cliffs — its historically strong brand and scale could help it bounce back. Johnson & Johnson (JNJ): For those preferring a steadier ride, J&J stands out as a reliable dividend stalwart with a balanced portfolio across pharmaceuticals and medical devices. Its modest valuation and diversified business make it a sensible pick for conservative, buy‑and‑hold investors. Why these names? The author argues that while many hot‑growth stocks command sky-high valuations (and thus high risk), these three represent more conservative bets — combining reasonable pricing, stable dividends, and long-term viability. If you’re in it for the long haul, these may be your top targets today. #stockmarket #valueinvesting #dividends #longterminvesting #SlimScan #GrowthStocks #CANSLIM